Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: A case study of public documents

CONCLUSION: In this sample of extended-release methylphenidate drug applications for adult ADHD, 8 of 13 regulatory decisions were missing entire trials according to public documents, even though regulatory requirements seem to stipulate that all available trials should be included in drug applications.

via https://pubmed.ncbi.nlm.nih.gov/34752938/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20211127011003&v=2.15.0


Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>